St. Louis School of Medicine: $5 Million Grant Supports Innovative Immunotherapies Against Blood Cancers
May 11, 2024
May 11, 2024
ST. LOUIS, Missouri, May 11 -- The Washington University St. Louis School of Medicine issued the following news release:
Researchers at Washington University School of Medicine in St. Louis have received a $5 million grant from the Leukemia & Lymphoma Society (LLS) to support research aimed at developing new immunotherapies for different types of blood-based cancers.
The goal of this team science program -- directed by Todd Fehniger, MD, PhD, and Brad Kahl, MD, both . . .
Researchers at Washington University School of Medicine in St. Louis have received a $5 million grant from the Leukemia & Lymphoma Society (LLS) to support research aimed at developing new immunotherapies for different types of blood-based cancers.
The goal of this team science program -- directed by Todd Fehniger, MD, PhD, and Brad Kahl, MD, both . . .